Nath Bio-Genes

161.85
+3.13
(1.97%)
Market Cap
301.60 Cr
EPS
21.34
PE Ratio
7.74
Dividend Yield
1.27 %
Industry
FMCG
52 Week High
264.31
52 Week low
151.00
PB Ratio
0.47
Debt to Equity
0.18
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
376.25 13,261.60 22.41 7,822.10 12.08 598 -4.72 45.56
274.65 6,430.70 14.73 5,481.60 0.44 596 -0.90 46.16
980.45 5,214.40 17.17 1,211.60 7.67 300 34.23 55.99
108.08 4,963.30 16.08 5,071.40 1.77 346 -29.17 39.68
95.38 1,734.60 26.33 1,081.70 -10.58 67 63.37 35.12
294.35 1,507.40 15.35 1,365.20 -2.40 116 -25.06 40.29
217.48 1,317.50 21.24 1,345.00 -3.39 61 -12.90 46.96
174.56 1,098.20 45.35 1,390.20 17.14 18 47.83 42.71
62.73 974.80 21.78 529.80 -9.36 53 -3.57 27.68
7.12 696.90 31.09 876.90 25.74 17 44.90 33.14
Growth Rate
Revenue Growth
10.40 %
Net Income Growth
13.14 %
Cash Flow Change
94.40 %
ROE
6.38 %
ROCE
2.12 %
EBITDA Margin (Avg.)
-7.23 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
28
209
22
25
45
235
23
34
44
244
32
37
Expenses
137
175
17
20
41
198
18
26
39
207
27
29
EBITDA
-109
35
5
6
4
37
5
8
5
37
5
9
Operating Profit %
-405 %
16 %
22 %
22 %
9 %
16 %
22 %
18 %
9 %
15 %
15 %
22 %
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
Interest
3
3
3
3
2
3
2
3
1
2
3
4
Profit Before Tax
-113
31
2
2
2
34
2
5
3
34
1
4
Tax
4
0
0
1
0
0
0
1
1
0
0
1
Net Profit
-116
31
2
1
1
33
2
4
3
33
1
3
EPS in ₹
-61.22
16.18
0.77
0.71
0.77
17.59
0.86
2.02
1.87
17.49
0.53
1.33

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
740
793
880
Fixed Assets
245
244
250
Current Assets
468
521
572
Capital Work in Progress
0
0
0
Investments
5
5
6
Other Assets
490
543
625
Total Liabilities
740
793
880
Current Liabilities
194
217
262
Non Current Liabilities
3
3
8
Total Equity
542
573
610
Reserve & Surplus
523
554
591
Share Capital
19
19
19

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
-25
34
39
Investing Activities
-20
-3
-27
Operating Activities
17
38
75
Financing Activities
-22
-2
-8

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
40.86 %
41.03 %
41.03 %
41.03 %
41.05 %
41.07 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
45.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.22 %
0.00 %
0.27 %
0.22 %
0.19 %
0.19 %
DIIs
8.55 %
8.55 %
8.44 %
7.16 %
4.85 %
4.62 %
4.62 %
4.62 %
4.62 %
4.62 %
4.37 %
4.37 %
4.37 %
4.38 %
4.37 %
4.37 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.19 %
21.09 %
22.92 %
25.79 %
29.86 %
31.29 %
31.61 %
30.62 %
30.17 %
30.37 %
30.50 %
30.95 %
32.25 %
32.43 %
31.54 %
31.75 %
Others
29.40 %
29.33 %
27.61 %
26.02 %
24.24 %
23.02 %
18.18 %
19.16 %
19.62 %
19.42 %
19.31 %
19.08 %
17.51 %
17.39 %
18.31 %
18.09 %
No of Share Holders
25,630
31,673
33,272
33,926
35,610
35,484
35,470
34,749
33,960
33,502
34,365
34,263
35,132
35,834
35,423
35,056

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 2 2 2 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 1.43 1.15 1.26 0.00

Corporate Action

Technical Indicators

RSI(14)
Neutral
37.04
ATR(14)
Volatile
8.16
STOCH(9,6)
Neutral
24.67
STOCH RSI(14)
Neutral
48.00
MACD(12,26)
Bearish
-0.43
ADX(14)
Strong Trend
27.52
UO(9)
Bearish
36.31
ROC(12)
Downtrend And Accelerating
-8.42
WillR(14)
Neutral
-69.71